Frontiers in Genetics (Jul 2020)
Corrigendum: Pioglitazone Improves Mitochondrial Organization and Bioenergetics in Down Syndrome Cells
- Nunzia Mollo,
- Maria Nitti,
- Maria Nitti,
- Lucrezia Zerillo,
- Deriggio Faicchia,
- Teresa Micillo,
- Rossella Accarino,
- Agnese Secondo,
- Tiziana Petrozziello,
- Gaetano Calì,
- Rita Cicatiello,
- Ferdinando Bonfiglio,
- Viviana Sarnataro,
- Rita Genesio,
- Antonella Izzo,
- Paolo Pinton,
- Giuseppe Matarese,
- Giuseppe Matarese,
- Simona Paladino,
- Anna Conti,
- Lucio Nitsch,
- Lucio Nitsch
Affiliations
- Nunzia Mollo
- Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy
- Maria Nitti
- Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy
- Maria Nitti
- Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy
- Lucrezia Zerillo
- Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy
- Deriggio Faicchia
- Institute of Experimental Endocrinology and Oncology, National Research Council, Naples, Italy
- Teresa Micillo
- Department of Biology, University of Naples Federico II, Naples, Italy
- Rossella Accarino
- Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy
- Agnese Secondo
- Department of Neuroscience, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy
- Tiziana Petrozziello
- Department of Neuroscience, Reproductive and Odontostomatological Sciences, University of Naples Federico II, Naples, Italy
- Gaetano Calì
- Institute of Experimental Endocrinology and Oncology, National Research Council, Naples, Italy
- Rita Cicatiello
- Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy
- Ferdinando Bonfiglio
- Department of Biomedicine, University of Basel, Basel, Switzerland
- Viviana Sarnataro
- Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy
- Rita Genesio
- Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy
- Antonella Izzo
- Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy
- Paolo Pinton
- Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy
- Giuseppe Matarese
- Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy
- Giuseppe Matarese
- Institute of Experimental Endocrinology and Oncology, National Research Council, Naples, Italy
- Simona Paladino
- Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy
- Anna Conti
- Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy
- Lucio Nitsch
- Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy
- Lucio Nitsch
- Institute of Experimental Endocrinology and Oncology, National Research Council, Naples, Italy
- DOI
- https://doi.org/10.3389/fgene.2020.00728
- Journal volume & issue
-
Vol. 11
Abstract
No abstracts available.Keywords
- Down syndrome/therapy
- pioglitazone
- energy metabolism
- oxidative stress
- mitochondrial dysfunction
- mitochondrial dynamics
